A new study published in The Journal of Immunology found that a high-salt diet (HSD) induces depression-like symptoms in mice by driving the production of a protein called IL-17A.

Studies conducted in human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) compared various cassette configurations and informed the final design of TN-201, which incorporates a ...

Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating biotech and advancing early and late-stage innovative ...

Cardiology Fellow, UMKC Healthcare Institute for Innovations in Quality, Saint Luke's Mid America Heart Institute ... any ...

FDA 510(k) clearance of Caristo's CaRi-Plaquetm technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinicsThe CaRi-Plaque ...

March 04, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or ... is pleased to announce that the United States Patent and Trademark Office has issued a Notice of Allowance for ...

On Tuesday, the FDA accepted for review Capricor Therapeutics Inc’s CAPR Biologics ... DMD cardiomyopathy is a heart condition characterized by cardiac fibrosis, arrhythmias, and heart failure.

and heart failure. Additionally, the FDA granted the BLA Priority Review with a Prescription Drug User Fee Act (PDUFA) target action date of August 31, 2025. The FDA has not identified any potential ...

--(BUSINESS WIRE)--Cadrenal Therapeutics ... heart pumps have set the standard in LVAD therapy. The HeartMate 3™ LVAD is the most advanced LVAD yet and the only one currently available in the ...

Abbott’s heart pumps have set the standard in LVAD therapy. The HeartMate 3™ LVAD is the most advanced LVAD yet and the only one currently available in the United States. According to Business ...

LGT Fund Management Co Ltd. acquired a new stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and ...

HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $ ...